2011 February 11
Johannesburg
Exco 2011 introduction Savi Chetty-Tulsee (Chair) Independent Judith Ramuthaga (Vice) Pharma Tebogo Sebata (Treasurer) Pharma Robert Voogt (Secretary CT) Laboratory Diederik van Niekerk (Bloem) Independent Dr Francois Burger CRO & Investigator Natalie Dresse Logistics Nicky Sulzer Study Coordinator Dr Luthando Adams SMO & Investigator Catherine Lund CRO Barbara Sematimba Full time administrator
Updates of 2010 activity
Sub-group activities CRA unit standard development Regulatory working group for CTF review Facilitation of the GCP sub-committee of
stakeholders (SCT chair of committee) ITG meetings with registrar and
development of good relations with MRA
Updates of 2010 activity Regulatory approval timeline tracking Dispensing w/group
Collaboration with PIASA for common objectives
Marketing of SA Survey on regulatory barriers in SA
Journal of Clinical studies Jan11articles
Updates
CRA Unit Standards: Still at the CHIETA SGB – no news
Regulatory w/group review of CTF: Completed review of CTF1, 2 and 3. Pending progress report. Requested meeting with MRA to discuss proposed changes
Update GCP subcommittee of industry stakeholders
Approval by HPCSA to review and accredit GCP providers
2011 – all providers to submit applications to HPCSA accreditor ( CPD2A form + GCP provider application forms)
CPD accreditation to serve as educational point allocation as well as confirmation that the GCP provider meets the industry set criteria
9Feb11: Training of HPCSA accreditors on the review of the application process conducted
Update ITG has requested a meeting with the
SAHPRA project w/group to get a status update
MCC review and approval timeline tracking will recommence Feb11.
Collaboration with PIASA will continue Development of a marketing SA package Survey of regulatory barriers report and
liaison with stakeholders Dispensing License – legal review (in
progress)
Updates
Publications Encourage positive publications on SA Education initiatives to increase lay
persons’ clinical trial knowledge
Recognition of excellence Site of the Year Clinical Research Associate of the Year Study Site Coordinator of the YearThe person nominating the individual needs to check against the
criteria in providing a brief summary of their experiences with working with the individual and provide examples of how this person went “over and above the call of duty”. This will help the judges in the decision making process. Any suggestions??
Nominations open on SACRA website Send emails to SACRA Coordinator
Visit website for criteria!!
Expectations from our membership
Increased members across stakeholders
Increased membership involvement in activities and projects
Increased interaction through use of technology
Pride, support and loyalty from within membership
2011 stakeholder focus
Sites & Study Coordinators (1)
Increasing site capacity by raising the awareness of clinical research amongst clinical staff.
There are many experienced clinicians in South Africa (doctors, nurses, allied health industry members) who potentially have a lot to add to our industry.
Information sessions to be hosted by relevant SACRA members in each area where interested parties can gather to hear what is involved in becoming a research site and receiving useful information and contacts.
Sites & Study Coordinators (2)
Increasing business skills’ knowledge amongst site staff. Clinical research is first and foremost a business & equipping relevant site staff with simple business skills is important to the efficient management of a site.
If the decision this year is to host a conference perhaps SACRA could once again invite Christine Pierre to host a ‘Site business skills’ workshop.
If there is to be no conference this year, perhaps SACRA & it’s partners could co-ordinate a site workshop where topics could include business skills, QC, SOP design and other topics suggested by interested attendees.
Service Providers (Natalie Dresse) Export Permit Information: May11 meeting
Application document completion Application process FAQ’s
IATA Training requirements for investigator sites: Last meeting IATA regulation training Roles & responsibilities in transportation
SMO/Investigators (Dr Luthando Adams, Dr Francois Burger)
Review of Investigator fees/ budgets based on submitted costs.
Review of Investigator sites payment terms. Capacity Building of sites Foster more early patient research activity in
SA Improve cross networking amongst Investigator Collaboration with PIASA/SACRA to develop a
marketing package/brochure
CRO’s - Catherine Lund, Dr Francois Burger Marketing and branding of SA Investigator database to be utilised by
CROs for clinical trial study related information
Bench marking survey on CRA salaries on the lines of expertise and skill set
Education initiative (articles in magazines to improve clinical research understanding)
Pharma- Tebogo Sebata Judith Ramuthaga
Continue ITG membership Restart MCC tracking Identify structure for corporate
membership fees Education initiative (articles in
magazines to improve clinical research understanding)
Independents - Savi Chetty-Tulsee, Diederik van
Niekerk To impress the importance for
continued education perhaps through small group meetings.
Maintaining communication network is a challenge.
The non involvement gaps identified may include budget constraints.
Propose a client & independents survey on what education the independents require.
How often should the SACRA Conference be held How often should the SACRA Conference be
held? Bi-Annually (Every 2 Years)
32 62.7% Annually (No change)
11 21.6% Every 18 Months
8 15.7% Number of Voters: 51
Website management, Yearly memberships carry yearly user name and password When renewing, it means you need to “re-register yearly !! Company invoices generated on the home-page-Public
menu-Multiple invoice request Individual invoices generated at the “Become a member” Or when you log on the your membership has expired, you
need to “renew here”. Choose payment option and please be careful to give
correct details Coupon code is then sent to you & needs to be used within
3 weeks to activate your access and log in into the members
How to activate your account
Coupon Code: ZJG3YJ Valid for No. of Subscriptions: 1 Valid for Plans: Full Time Instructions:
1. Click the 'Become a Member' button on the right-hand side of the site. 2. Enter all your personal information and click 'Register'. 3. Select your Subscription Plan.
(You must choose one of the Existing Plans) 4. You can use either Offline Payment or Credit Card (as you will not be making an actual
payment). 5. Enter the Coupon Code for Full Time Membership (Existing Members) - this will apply a 100%
plan discount. 6. Complete the registration process.
Activate your Membership by clicking the activation link provided in the Activation E-mail which you will receive shortly after completing the process
What’s new (1) The FDA amended the regulations governing the
informed consent process for clinical research studies of products regulated by the FDA, at 21 C.F.R. § 50.25(c).
This final rule was published on January 4, 2011 and it is effective March 7, 2011. The final rule requires that all informed consent documents for “applicable” drug (including biological product) and device clinical trials include a statement to inform individual subjects in the trials that a description of the clinical trial will be made available on the National Institutes of Health/National Library of Medicine (NIH/NLM) website at clinicaltrials.gov. The statement must also indicate clinicaltrials.gov will not include individually identifiable information. Compliance date: The compliance date of this final rule is March 7, 2012, for clinical trials that are initiated on or after the compliance date.
What’s new (2)
FDA Draft Guidance for Industry: Electronic Source Documentation
in Clinical Investigations, December 2010
www.fda.org
What’s new (3)
International Compilation of Human Research Protections
2011 Edition Compiled By:
Office for Human Research Protections, U.S. Department of Health and Human Services
http://www.hhs.gov/ohrp/international/
What’s new (3) cont. is a listing of over 1,000 laws,
regulations, and guidelines on human subjects protections in over 100 countries and from several international organizations. Many of the listings embed hyperlinks to the source document. These laws, regulations, and guidelines are classified into six categories:
General Drugs and Devices Privacy/Data Protection Human Biological Materials Genetic Issues Embryos, Stem Cells, and Cloning
Top Related